期刊文献+

托吡酯促进体外培养神经干细胞增殖的实验研究

Topiramate Promotes Proliferation of Neural Stem Cells in Vitro
原文传递
导出
摘要 目的:研究托吡酯对体外培养神经干细胞的促增殖作用。方法:取新生小鼠大脑进行神经干细胞原代培养,托吡酯按0.4、2、10μmol.L-13个量级(或3种浓度)加入神经干细胞培养基中,同时设立溶媒对照组和阳性对照组,通过神经球生成数目及MTT法定量比较,分析不同浓度托吡酯对神经干细胞分裂增殖的影响。结果:2、10μmol.L-1托吡酯组神经球数目分别为20.67±4.04和49.68±3.79;MTT比色结果分别为0.3546±0.0705和0.5018±0.0369,明显高于溶媒对照组(7.34±2.31、0.2880±0.0093,P<0.01)。结论:托吡酯具有促进神经干细胞增殖的作用。 OBJECTIVE: To study the effects of topirmate on proliferation of neural stem cells in vitro. METHODS: Primary neural stem cells from newborn mice were cultured. The neural stem cells were incubated together with topiramate at 0.4, 2 or 10μmol · L^- 1. A vehicle control and positive control were set up, respectively. The quantity and viability of neural stem cells newly generated were analyzed by a convert phase microscope, the neurosphere numbers were counted, and neural stem cells viability was delermined and a MTT assay. RESULTS: The number of neurospheres of groups treated with topiramate at 2 and 10μmol · L^- 1 are 20.67± 4.04 ,49.68± 3.79, respectively, and the value of MTT assay of the two groups are 0.354 6 ± 0.070 5, 0. 501 8 ± 0. 036 9, it was higher than the vehicle control neural stem cells(7.34 ± 2.31,0. 288 0 ± 0. 009 3, P〈0.01). CONCLUSION: Topiramate has the potential for the stimulation of proliferation of neural stem cells.
出处 《中国药房》 CAS CSCD 北大核心 2008年第1期25-27,共3页 China Pharmacy
关键词 托吡酯 神经干细胞 增殖 MTT法 Topiramate Neural stem cells Proliferation MTT method
作者简介 主治医师,硕上。研究方向:神经康复。电话:0719—8801366。Email:zhuxh0831@163.com 通讯作者:副主任医师,硕士研究牛导师。研究方向:神经康复。电话:07198801366
  • 相关文献

参考文献9

  • 1Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system [J ] . Science, 1992,255(5 052) : 1 707.
  • 2Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders[J ]. Nat Neurosci, 2000,3(6) : 537.
  • 3Cattaneo E, Mckay R. Proliferation and differentiation of neuronal stem cells regulated by nerve grow th factor[J ] .Nature, 1990,347(6 295) : 762.
  • 4常健,赵红霞,李海波,鲁继荣,杨立彬.托吡酯治疗儿童多发性抽动症疗效评估[J].中国妇幼保健,2006,21(9):1211-1213. 被引量:9
  • 5袁强,吕秀英.妥泰与心得安预防偏头痛发作的初步随机对照研究[J].华西药学杂志,2005,20(2):181-182. 被引量:3
  • 6Coulter DA, Sombati S, Delorenzo RJ. Topiramate effects on excitatory amino acid mediated responses in cultured hippocampal neurons: selective blockade kainite currents [J ]. Epilepsia, 1995,36(Suppl 3) : S40.
  • 7Yang Y, Shuaib A, Li Q. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization[J ] .Brain Research, 1998, 804(2) : 169.
  • 8Lee SR, Kim SP, Kim JE. Protective effect of topiramate against hippocampal neural damage after global ischemia in the gerbils[J] . Neurosicence Letters, 2000, 281(2) : 183.
  • 9Mikael A, Elinor BM, Lars R, et al. Topiramate protects against glutamate - and kainate - induced neurotoxicity in primary neuronal- astroglial cultures[J]. Epilepsy Research , 2003,54(1) : 63.

二级参考文献12

  • 1Nieto- Barrera M. Characteristics and indications of topiramate [ J ].Rev Neurol, 2002, 35 suppll: 88.
  • 2Headache Classification Committee of the International Headache Society, Classification and diagnostic criteria for headache disorders,cranial neuralgias and facial pain [ J ]. Cephalalgia, 1988, 8 ( suppl 7): 1.
  • 3Silberstein SD, Neto W, Schmitt J, et al. Topiramate in migraine prevention: results of a large controlled trial [J]. Arch Neurol,2004, 61 (4): 490.
  • 4Brandes JL, Saper JR, Diamond I, et al. Topiramate for Migraine prevention: a randomized controlled trial [J]. JAMA, 2004, 291(8): 965.
  • 5Abuzzahab FS,Brown VL.Control of Tourette's syndrome with topiramate.Am J Psychiatry,2001,158:968
  • 6American Psychiatric Association.Diagnostic and statistical manual of menta disorders.4ed.Washington:American Psychiatric Association,1994:100 ~ 105
  • 7Leckman JF,Riddle MA,Hardin MTet al.The Yale Global Tie Severity Scale:initial testing of a clinician-rated scale of tie severity.J Am Acad Child Adolesc Psychiatry,1989,28:566
  • 8Singer HS.Neurobiology of Tourette syndrome.Neurol Clin,1997,15:357
  • 9Singer HS,Wendlandt J,Krieger M,Giuliano J.Baclofen treatment in Tourette syndrome:a double-blind,placebo-controlled,crossover trial.Neurology,2001,56:599
  • 10Kurlan R.The pathogenesis of Toutette's syndrome:a possible role for hormonal and excitatory neurotransmitter influnces in brain development.Arch Neurol,1992,49:874

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部